August 10, 2023 – The PPD clinical research business of Thermo Fisher Scientific has been granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health in the United States. This center will offer a broad range of support services critical to the design, development, execution and analysis of NIAID transplantation clinical trials and research.
According to the United Network for Organ Sharing, the non-profit serving as the nation’s transplant system under contract with the federal government, more than 40,000 organ transplants were performed in 2022, setting an annual record, with total kidney transplants exceeding 25,000 for the first time ever. Meanwhile, the Health Resources & Services Administration within the U.S. Department of Health and Human Services notes that more than 100,000 people are on the national transplant waiting list for all organs combined.
Research advances continue to expand understanding of the biological mechanisms of solid organ transplant rejection and acceptance, yielding significant improvement in one-year survival rates and quality of life. While design of clinical trials in this field can be challenging, the PPD clinical research business has the tools and expertise necessary to help sponsors develop successful, cost-effective studies that minimize site and patient burden.
Thermo Fisher’s PPD clinical research business has three decades of experience successfully delivering clinical research services to governmental agencies, contractors and nonprofits. The business has conducted therapeutic, vaccine and medical device studies on a global scale across all trial phases and a broad array of therapeutic areas. During the past five years, it has conducted nearly 150 studies in transplantation and related indications, involving more than 7,000 patients at more than 2,200 research sites around the world. More broadly, Thermo Fisher’s transplant diagnostics business offers advanced solutions to help improve quality of life for transplant patients.
The center will provide services such as statistical design and analysis; clinical protocol development, implementation and study management; biospecimen tracking; manuscript publication support; study management team organization and maintenance; and collaboration with other stakeholders to plan, oversee, execute and analyze NIAID-sponsored transplantation research.